4594 BrightPath Biotherapeutics Co., Ltd. - News - Kabutan

66,020.04

+2.81%

3,881.96

+1.35%

160.35

+0.25%

4594

TSE Growth

BrightPath Biotherapeutics Co., Ltd.

Result

44

JPY

-1

(-2.22%)

Jun 12, 3:30 pm JST

0.27

USD

Jun 12, 2:30 am EDT

PER

ー

PBR

2.60

Yield

ー%

Margin Trading Ratio

13.42

PTS

outside of trading hours

44.1

Jun 12, 11:58 pm JST

Summary Chart Historical News Financial Result

The Oldest Date: Sep 2, 2024

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

2024

2025

2026

Clear

BrightPath Biotherapeutics, The Current Fiscal Year's Net Income to Widen

Thu May 14, 2026 3:32 pm JST Earnings
BrightPath Biotherapeutics, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision

Fri Mar 13, 2026 3:30 pm JST Revision
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens

Fri Feb 13, 2026 3:32 pm JST Earnings
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens

Fri Nov 14, 2025 3:32 pm JST Earnings
BrightPath Biotherapeutics, Apr-Jun (1Q) Net Income Loss Narrows

Fri Aug 8, 2025 3:30 pm JST Earnings
BrightPath Biotherapeutics, Continue Net Income Turns to Loss

Fri May 9, 2025 3:30 pm JST Earnings
BrightPath Biotherapeutics, The Current Fiscal Year Net Income Loss Widened in Downward Revision

Mon Mar 24, 2025 6:00 pm JST Revision
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows

Fri Feb 14, 2025 3:30 pm JST Earnings
BrightPath Biotherapeutics Co., Ltd., First Half Net Income Loss Narrows, July-September Net Income Loss Narrows

Fri Nov 8, 2024 3:30 pm JST Earnings